Prolor Biotech Inc. has obtained formal Good Manufacturing Practice (GMP) certification for its hGH-CTP human growth hormone. GMP certification is required by EU clinical trials legislation as a precondition for conducting clinical trials in EU member countries. hGH-CTP is a proprietary biobetter therapeutic protein for the long-term treatment of children and adults with growth hormone deficiency due to inadequate secretion of endogenous growth hormone. The drug can be injected weekly or monthly, compared with the daily injections needed for current products. The company estimates global sales of growth hormone products at $3 billion a year. http://www.globes.co.il/serveen/globes/docview.asp?did=1000570538&fid=1725
News for June, 2010
Prolor rises on growth hormone production permit
Wednesday, June 30th, 2010Perrigo buys US rights to generic Allegra from Teva
Wednesday, June 30th, 2010Perrigo Company has acquired the exclusive US rights to generic Allegra from Teva Pharmaceutical Industries Ltd.. Perrigo sell and distribute store brand and over-the-counter versions of the drug, after Teva and Sanofi-Aventis settled litigation over it. Allegra is a treatment for seasonal allergies. Brand versions of the prescription drug had $2.1 billion in US sales altogether in 2009. http://www.globes.co.il/serveen/globes/docview.asp?did=1000570539&fid=1725
NICE successfully integrates solution for Motorola
Wednesday, June 30th, 2010NICE Systems Ltd. has successfully completed integration testing of its NICE Inform, incident information management solution for public safety organizations, for Motorola’s TETRA (Terrestrial Trunked Radio) DIMETRA IP release 7. The integration of NICE Inform with the new DIMETRA release enables police, fire and ambulance services personnel with a cost efficient, IP-based solution for the recording, playback and storage of end-to-end encrypted public safety radio calls. NICE Inform can be implemented right at the heart of the TETRA network to offer public safety professionals the assurances they need for the security and reliability of their communications storage and retrieval. http://www.globes.co.il/serveen/globes/docview.asp?did=1000570427&fid=1725
Cleantech can be growth engine for Israel
Wednesday, June 30th, 2010Israel has relative advantages in cleantech sectors, including innovation, entrepreneurship, human capital, and R&D, which can help Israeli companies succeed and advance in the industry, said Governor of the Bank of Israel Prof. Stanley Fischer at the 14th CleanTech 2010 Expo in Tel Aviv today. Fischer added that Israel has extensive experience in financing innovation through venture capital, and start-ups. Government incentives are important, but private sector financing should lead the industry’s development. Cleantech development in Israel has many economic advantages. It can serve as a growth engine, and help diversify exports and export targets, which will reduce the economy’s vulnerability to crises. Cleantech can also promote Israel’s environment, reduce the country’s dependence on imported fuels, and help Israel’s integration into the OECD. http://www.globes.co.il/serveen/globes/docview.asp?did=1000570404&fid=1725
